WHO Warns of Rising Antibiotic Resistance as Drug-Resistant Infections Increase Worldwide

New Delhi, July 26 : The World Health Organization (WHO) has renewed its warning over the growing threat of antimicrobial resistance (AMR), saying drug-resistant infections are becoming one of the biggest challenges facing global healthcare systems. Health experts have urged governments to strengthen surveillance, improve infection prevention and encourage responsible use of antibiotics to slow the spread of resistant bacteria.

The warning comes as several countries reported increasing cases of infections that no longer respond to commonly prescribed antibiotics. Medical professionals fear that routine illnesses and surgical procedures could become significantly more dangerous if current trends continue.

Drug Resistance Becoming a Major Public Health Threat

Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites evolve to withstand medicines designed to eliminate them. As resistance increases, infections become harder to treat, resulting in longer hospital stays, higher healthcare costs and greater risk of death.

According to health experts, the misuse and overuse of antibiotics remain the primary drivers behind the growing resistance. Antibiotics are frequently prescribed unnecessarily for viral illnesses or taken without completing the prescribed course, allowing resistant bacteria to survive and multiply.

Hospitals are also witnessing a rise in healthcare-associated infections caused by resistant organisms, particularly among elderly patients and those with weakened immune systems.

Hospitals Strengthen Infection Control

Healthcare institutions around the world are expanding infection prevention measures to reduce the spread of resistant bacteria. Hospitals are increasing screening of high-risk patients, improving sanitation protocols and promoting better hand hygiene among healthcare workers.

Medical experts stress that preventing infections is just as important as developing new medicines. Vaccination, safe surgical practices and improved sanitation can significantly reduce the need for antibiotics.

Several countries have also introduced antibiotic stewardship programs aimed at ensuring medicines are prescribed only when medically necessary.

Pharmaceutical Industry Faces Innovation Challenge

Researchers say the pipeline for new antibiotics remains limited despite growing demand for effective treatments. Developing new antimicrobial drugs requires significant investment, while financial returns remain relatively low compared to medicines for chronic diseases.

Governments and international organizations are encouraging public-private partnerships to accelerate antibiotic research and provide incentives for pharmaceutical companies developing innovative therapies.

Scientists are also exploring alternative approaches, including bacteriophage therapy, advanced diagnostics and artificial intelligence-based drug discovery.

Public Awareness Remains Essential

Health officials continue urging people to avoid self-medication, never use leftover antibiotics and follow doctors’ instructions carefully when prescribed antimicrobial medicines.

Experts believe public education will play a critical role in slowing resistance and preserving the effectiveness of existing treatments.